Davis J. E. sold $2.4M of DGX
Davis J. E. (CEO and President) sold 10,000 shares of QUEST DIAGNOSTICS INC (DGX) at $242.72 ($2.43M total) on 2026-09-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale adds a modest negative data point to DGX's recent positive momentum.
Market read
Insider sale is a primary disclosure that may influence short‑term trading sentiment for DGX.
What to watch
Recent earnings beat and strong cash flow may offset concerns from the insider sale.
Background
Form 4 filings disclose insider transactions; a 10b5‑1 plan indicates pre‑arranged sales.
Ticker impact
CEO Davis J. E. sold 10,000 shares for $2.4 M via a 10b5‑1 plan, reducing his stake to 122,423 shares.
Potential short‑term pressure on DGX, likely limited to a few percent.
Form 4 is primary disclosure; the $2.4 M sale is material enough to affect sentiment but not large enough to drive a major move.
Market effects
May prompt analysts to review insider sentiment across health‑care services.
Limited to U.S. markets; no broader regional effect.
Low global relevance; only impacts investors tracking Quest Diagnostics.
Counterpoint
The sale could be a routine liquidity event under a pre‑arranged plan, not a bearish signal.
Key entities
- CompanyQuest Diagnostics Inc.
Provider of diagnostic testing services, ticker DGX.
- ExecutiveDavis J. E.
CEO and President of Quest Diagnostics.
